M. Hemida

Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients

Background While injectable GLP-1 receptor agonists like semaglutide have demonstrated clear cardiovascular benefits in type 2 diabetes mellitus (T2DM), the role of oral incretin-based therapies, including oral semaglutide and DPP-4 inhibitors—remains less well defined. Comprehensive evaluation of their cardiovascular...

Nationwide mortality trends for non-alcoholic fatty liver disease and diabetes mellitus in the U.S. (1999–2022): insights from the CDC WONDER database

Breast cancer and diabetes mellitus–related mortality among U.S. adults: a 25-year CDC WONDER analysis (1999–2023)

Trends and disparities in acute myocardial infarction mortality with contributing hyperlipidemia in the United States, 1999-2024.

The rate of AMI deaths in which hyperlipidemia was documented as contributing condition increased significantly over the 26-year study period, with steepest trends observed in males, NH Black, older aged, the southern region, and rural areas.

Trends and disparities in colorectal cancer mortality among adults with diabetes mellitus in the United States: A retrospective analysis, 1999–2025 and projections to 2040

CRC and DM-related mortality demonstrated an overall declining trend and is projected to continue declining through 2040, and Disparities among men, NH Blacks and older adults require refined strategies to improve outcomes.

National Trends in Pancreatic Cancer-Related Mortality: A Population-Based Analysis of Rural–Urban Disparities and the Distribution of Place of Death

A consistent rise in pancreatic cancer-related mortality with an increasing trend for rural areas emphasizes the discrepancy and the possible need for targeted interventions.